TrademarkDir
VIVENK
LIVE

Serial Number

79300658

Owner

Glycostem Therapeutics B.V.

Attorney

Michael M. Morris

Filing Date

Nov 27, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

VIVENK Trademark

Serial Number: 79300658 • Registration: 7349251

VIVENK is a trademark filed by Glycostem Therapeutics B.V. on November 27, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Glycostem Therapeutics B.V. (6 trademarks)

Pivot Park,

Entity Type: 16

Trademark Details

Filing Date

November 27, 2020

Registration Date

April 9, 2024

Published for Opposition

January 23, 2024

Goods & Services

Pharmaceutical products and preparations containing natural killer cells for the treatment of cancer; medical cell products for the treatment of cancer in the nature of natural killer cells for use in immuno-oncology

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 17, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 30, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 30, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 19, 2024 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 9, 2024 R.PR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 9, 2024 NRCC
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 23, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Jan 22, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 3, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 3, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 3, 2024 NONP
EXPARTE APPEAL TERMINATED
Dec 18, 2023 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 18, 2023 CNSA
NEW REPRESENTATIVE AT IB RECEIVED
Dec 9, 2023 NREP
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 7, 2023 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jul 12, 2022 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Jul 12, 2022 GECD
ACTION CONTINUING FINAL - COMPLETED
Jul 12, 2022 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2022 CRFA
ASSIGNED TO LIE
Jun 24, 2022 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 14, 2022 ERFR
EX PARTE APPEAL-INSTITUTED
Jun 14, 2022 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 14, 2022 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jun 14, 2022 EXAF
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 12, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 25, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 25, 2022 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 14, 2021 GNFN
FINAL REFUSAL E-MAILED
Dec 14, 2021 GNFR
FINAL REFUSAL WRITTEN
Dec 14, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 18, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2021 TROA
REFUSAL PROCESSED BY IB
Jun 13, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 21, 2021 RFCS
REFUSAL PROCESSED BY MPU
May 21, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 20, 2021 RFCR
NON-FINAL ACTION WRITTEN
May 19, 2021 CNRT
ASSIGNED TO EXAMINER
May 13, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 1, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 24, 2020 REPR

Related Trademarks

More from this Owner

GLYCOSTEM logo

GLYCOSTEM

GLYCOSTEM logo

GLYCOSTEM

GLYCOSTEM logo

GLYCOSTEM

GLYCOSTEM

GLYCOSTEM

GLYCOSTEM

GLYCOSTEM

GLYCOSTEM

GLYCOSTEM